EPPIK (Phase 2 Study): Treatment in Pediatric Patients With Proteinuric Glomerular Diseases

FILSPARI (sparsentan) – Acute Kidney Injury

FILSPARI (sparsentan) Dual Receptor Antagonism in Renal Pathophysiology and Reduction of Proteinuria

FILSPARI (sparsentan) – Changes in Blood Pressure and Hypotensive Events

FILSPARI (sparsentan) – Drug-Drug Interactions

FILSPARI (sparsentan) – Pharmacokinetic Profile